WO2001022917A8 - Effervescent compositions comprising nimesulide - Google Patents

Effervescent compositions comprising nimesulide

Info

Publication number
WO2001022917A8
WO2001022917A8 PCT/IN2000/000093 IN0000093W WO0122917A8 WO 2001022917 A8 WO2001022917 A8 WO 2001022917A8 IN 0000093 W IN0000093 W IN 0000093W WO 0122917 A8 WO0122917 A8 WO 0122917A8
Authority
WO
WIPO (PCT)
Prior art keywords
nimesulide
effervescent compositions
carbonate source
effervescent
compositions
Prior art date
Application number
PCT/IN2000/000093
Other languages
French (fr)
Other versions
WO2001022917A2 (en
WO2001022917A3 (en
Inventor
Amarjit Singh
Rajesh Jain
Original Assignee
Panacea Biotec Ltd
Amarjit Singh
Rajesh Jain
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panacea Biotec Ltd, Amarjit Singh, Rajesh Jain filed Critical Panacea Biotec Ltd
Priority to AU28798/01A priority Critical patent/AU2879801A/en
Publication of WO2001022917A2 publication Critical patent/WO2001022917A2/en
Publication of WO2001022917A3 publication Critical patent/WO2001022917A3/en
Publication of WO2001022917A8 publication Critical patent/WO2001022917A8/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent

Abstract

An effervescent Pharmaceutical composition comprising the drug Nimesulide, one or more acids and one or more carbonate source wherein the ratio between Nimesulide and the total carbonate source is between 1:17 to 1:2 w/w.
PCT/IN2000/000093 1999-09-28 2000-09-27 Effervescent compositions comprising nimesulide WO2001022917A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU28798/01A AU2879801A (en) 1999-09-28 2000-09-27 Effervescent compositions comprising nimesulide

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1296/DEL/99 1999-09-28
IN1296DE1999 IN190018B (en) 1999-09-28 1999-09-28

Publications (3)

Publication Number Publication Date
WO2001022917A2 WO2001022917A2 (en) 2001-04-05
WO2001022917A3 WO2001022917A3 (en) 2001-12-27
WO2001022917A8 true WO2001022917A8 (en) 2002-06-20

Family

ID=11092666

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2000/000093 WO2001022917A2 (en) 1999-09-28 2000-09-27 Effervescent compositions comprising nimesulide

Country Status (3)

Country Link
AU (1) AU2879801A (en)
IN (1) IN190018B (en)
WO (1) WO2001022917A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009501785A (en) * 2005-07-20 2009-01-22 パナセア バイオテック リミテッド Novel controlled release pharmaceutical formulation cyclooxygenase enzyme inhibitor
AU2007242405A1 (en) * 2006-04-24 2007-11-01 Panacea Biotec Ltd. Novel low dose pharmaceutical compositions comprising nimesulide, preparation and use thereof
MY157533A (en) 2008-02-08 2016-06-15 Colgate Palmolive Co Effervescent compositions
BE1018279A3 (en) * 2008-09-09 2010-08-03 Squarepoint Pointcarre Sprl ORODISPERSIBLE NIMESULIDE COMPOSITION.
RU2711090C2 (en) * 2015-01-23 2020-01-15 Др. Редди'С Лабораториз Лимитед Non-staining gel composition containing nimesulide, for topical application
CN114105839A (en) * 2020-08-27 2022-03-01 湖北舒邦药业有限公司 Pretreatment method of bulk drug and composition thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1293764B1 (en) * 1997-07-23 1999-03-10 Chiesi Farma Spa PHARMACEUTICAL COMPOSITIONS IN THE FORM OF EFFERVESCENT TABLETS CONTAINING AN UNSTABLE ACTIVE IN THE PRESENCE OF WATER
DK1001748T3 (en) * 1997-07-25 2006-08-21 Alpex Pharma Sa Process for the preparation of a granule suitable for the preparation of tablets which can be dissolved in the mouth which can be rapidly decomposed
IT1298732B1 (en) * 1998-03-13 2000-02-02 Recordati Chem Pharm ORAL PHARMACEUTICAL COMPOSITIONS ASSUMABLE WITHOUT LIQUIDS, CONTAINING INCLUSION COMPLEXES

Also Published As

Publication number Publication date
AU2879801A (en) 2001-04-30
IN190018B (en) 2003-05-31
WO2001022917A2 (en) 2001-04-05
WO2001022917A3 (en) 2001-12-27

Similar Documents

Publication Publication Date Title
AU2001290257A1 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU2001290257A2 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU2002232492A1 (en) Rapidly dispersing pharmaceutical composition comprising effervescent agents
EP2311488A3 (en) Vaccine composition
AU2001237525A1 (en) Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
CA2222676A1 (en) New pharmaceutical composition with anaesthetic effect
ZA200206905B (en) Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same.
AU2002306269A1 (en) N-arylphenylacetamide derivatives and pharmaceutical composition containing the same
AU2001230902A1 (en) Slow-release insect-repellent composition and uses
WO2000066104A3 (en) Ace-2 inhibiting compounds and methods of use thereof
CA2368574A1 (en) Compositions for preventing and treating type i allergy
EP1295879A4 (en) Medicinal compositions containing propenone derivatives
AU1887401A (en) Medicinal composition
AU2001275677A1 (en) 3,4-dihydroxybenzyl-substituted carbonic acid derivatives and the use thereof as antioxidants
CA2429639A1 (en) Stable azithromycin monohydrate
AU2001290239A1 (en) Medicinal composition
IL139318A (en) Sugar alcohol mixtures as therapeutic agents and pharmaceutical compositions containing the same
AU5647199A (en) Carboxylic acid derivatives and drugs containing the same as the active ingredient
AU2001232238A1 (en) Anti-acid-fast bacterial agents containing pyridonecarboxylic acids as the active ingredient
AU5443499A (en) Carboxylic acid derivatives and drugs containing the same as the active ingredient
WO2001022917A8 (en) Effervescent compositions comprising nimesulide
SE0001916D0 (en) Novel formulation
DE60004204D1 (en) PHARMACEUTICAL COMPOSITIONS INTENDED FOR THE ORAL ADMINISTRATION OF PHLOROGLUCINOL AND THE PRODUCTION THEREOF
AU3896899A (en) Compositions for the treatment of tumors, and uses thereof
AU2002341555A1 (en) Levothyroxine pharmaceutical compositions, methods of making and methods of administration

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

AK Designated states

Kind code of ref document: C1

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase in:

Ref country code: JP